APG-C-20
N/A
Report date: 2023/02/04 20:21:18
NME
Base Information
Drug NameAPG-C-20
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAvergen Pharmaceuticals GmbH
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAvergen Pharmaceuticals GmbH
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A